FindTrial
Sign In

Conversion of human thymic fibroblasts into cardiomyocytes via iPS cell induction.

Conversion of human thymic fibroblasts into cardiomyocytes via iPS cell induction. - Conversion of human thymic fibroblasts into cardiomyocytes via iPS cell induction.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000017638
Enrollment
20
Registered
2015-06-01
Start date
2015-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tetralogy of Fallot

Interventions

None listed

Sponsors

Saitama International Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Tetralogy of Fallot

Exclusion criteria

Exclusion criteria: no criteria

Design outcomes

Primary

MeasureTime frame
Conversion of human thymic fibroblasts into cardiomyocytes via iPS and myocardial cell induction.—

Countries

Japan

Contacts

Public ContactRyusuke Hosoda

Saitama International Medical Center Pediatric cardiac surgery

rhosoda@saitama-med.ac.jp042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026